Concert: Sun Pharma spends $576m to get hands on hair loss drug
The Indian company decides to purchase Concert Pharmaceuticals, which is developing deuruxolitinib as a potential treatment for alopecia areata.
Read full article »
Concert is a Massachusetts-based biopharmaceutical company that researches and develops small-molecule drugs for the treatment of autoimmune diseases.
Read more